Abstract
Objective To compare the efficacy of Crinone 8% intravaginal progesterone gel vs. IM progesterone for luteal phase and early pregnancy support after IVF-ET.
Design Randomized, open-label study.
Setting Academic medical center.
PATIENT(S): Two hundred and one women undergoing IVF-ET.
INTERVENTION(S): Women were randomized to supplementation with Crinone 8% (90 mg once daily) or IM progesterone (50 mg once daily) beginning the day after oocyte retrieval.
MAIN OUTCOME MEASURE(S): Pregnancy, embryo implantation, and live birth rates.
RESULT(S): The women randomized to luteal phase supplementation with IM progesterone had significantly higher clinical pregnancy (48.5% vs. 30.4%; odds ratio [OR], 2.16; 95% confidence interval [CI], 1.21, 3.87), embryo implantation (24.1% vs. 17.5%; OR, 1.89; 95% CI, 1.08, 3.30), and live birth rates (39.4% vs. 24.5%; OR, 2.00; 95% CI, 1.10, 3.70) than women randomized to Crinone 8%.
CONCLUSION(S): In women undergoing IVF-ET, once-a-day progesterone supplementation with Crinone 8%, beginning the day after oocyte retrieval, resulted in significantly lower embryo implantation, clinical pregnancy, and live birth rates compared with women supplemented with IM progesterone.
progesterone support IVF comparison, crinone versus intramuscular progesterone, vaginal progesterone gel ivf outcomes, luteal phase support IVF, intramuscular progesterone pregnancy rates, progesterone supplementation embryo transfer, crinone 8% effectiveness, progesterone delivery route comparison
Keywords
Administration, Intravaginal, Adult, Age Factors, Embryo Transfer, Estradiol/blood, Female, Fertilization in Vitro/methods, Gels/administration & Dosage, Humans, Injections, Intramuscular, Male, Ovulation Induction/methods, Pregnancy, Progesterone/administration & Dosage/analogs & Derivatives, Statistics, Nonparametric, Crinone, Gels, Progesterone, Estradiol,